Actual status of veralipride use

References

• HickeyMSaundersCMStuckeyBGANon-hormonal treatments for menopausal symptomsMaturitas200757858917367965
   PubMed Web of Science ®Google Scholar
• KronenbergFHot flashes: epidemiology and physiologyAnn NY Acad Sci199059252862197954
   PubMed Web of Science ®Google Scholar
• de LeoVMorganteGMusacchioMCFaldiniEDeliaAPetragliaFThe safety of veraliprideExpert Opin Drug Saf2006569570116907659
   PubMed Web of Science ®Google Scholar
• LoboRMenopause and agingStraussJFBarbieriRLYen and Jaffe’s Reproductive Endocrinology Physiology, Pathophysiology and Clinical Management6th edPhiladelphiaSaunders Elsevier2009325355
   Google Scholar
• BerendsenHHThe role of serotonin in hot flushesMaturitas20003615516411063896
   PubMed Web of Science ®Google Scholar
• NelsonHDVescoKKHaneyENon-hormonal therapies for menopausal hot flashesJAMA20062952057207116670414
   PubMed Web of Science ®Google Scholar
• Carranza-LiraSCortés-FuentesEModification of vasomotor symptoms after various treatment modalities in the postmenopauseInt J Gynecol Obstet200123169171
   Web of Science ®Google Scholar
• ReddySYWarnerHGuttusoTGabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trialObstet Gynecol2006108414816816054
   PubMed Web of Science ®Google Scholar
• BigliaNSgandurraPPeanoPNon-hormonal treatment of hot flushes in breast cáncer survivors: gabapentin vs vitamin EClimacteric20091231031819415540
   PubMed Web of Science ®Google Scholar
• EvansMLPrittsEVittinghoffEmanagement of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trialObstet Gynecol200510516116615625158
   PubMed Web of Science ®Google Scholar
• PhillipsBBDigmannRRBeckMGHepatitis associated with low-dose venlafaxine for postmenopausal vasomotor symptomsAnn Pharmacother20064032332716418323
   PubMed Web of Science ®Google Scholar
• LaddCONewportDJRaganKALoughheadAStoweZNVenlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depressionDepress Anxiety200522949716094663
   PubMed Web of Science ®Google Scholar
• ArcherDFDupontCMConstantineGDPickarJHOlivierSDesvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safetyAm J Obstet Gynecol2009200238.e1238.e1019167693
   PubMed Web of Science ®Google Scholar
• ArcherDFSeidmanLConstantineGDPickarJHOlivierSA double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopauseAm J Obstet Gynecol2009200172.e1172.e1019110224
   PubMed Web of Science ®Google Scholar
• SperoffLGassMConstantineGOlivierSEfficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trialObstet Gynecol2008111778718165395
   PubMed Web of Science ®Google Scholar
• StearnsVBeebeKLIyengarMDubeEParoxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trialJAMA20032892827283412783913
   PubMed Web of Science ®Google Scholar
• LoprinziCLSloanJAPérezEAPhase III evaluation of fluoxetine for treatment of hot flashesJ Clin Oncol2002201578158311896107
   PubMed Web of Science ®Google Scholar
• OktemMErogluDKarahanHBTaskintunaNKuscuEZeynelogluHBBlack cohosh and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized trialAdv Ther20072444846117565936
   PubMed Web of Science ®Google Scholar
• Suvanto-LuukkonenEKoivunenRSundstromHCitalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind studyMenopause200512182615668596
   PubMed Web of Science ®Google Scholar
• SoaresCNPoitrasJRProutyJAlexanderABShifrenJLCohenLSEfficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptomsJ Clin Psychiatry20036447347912716252
   PubMed Web of Science ®Google Scholar
• KalayAEDemirBHaberalAKalayMKandemirOEfficacy of citalopram on climacteric symptomsMenopause20071422322917224858
   PubMed Web of Science ®Google Scholar
• CoopeJWilliamsSPattersonJSA study of the effectiveness of propranolol in menopausal hot flushesBr J Obstet Gynaecol197885472475350262
   PubMedGoogle Scholar
• AlcoffJMCampbellDTribbleDOldfieldBCruessDDouble-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptomsClin Ther198133563647471131
   PubMed Web of Science ®Google Scholar
• BartonDLLoprinziCLQuellaSKProspective evaluation of vitamin E for hot flashes in breast cancer patientsJ Clin Oncol1998164955009469333
   PubMed Web of Science ®Google Scholar
• BigliaNSgandurraPPeanoENon-hormonal tratment of hot flushes in breast cancer survivors: gabapentin vs vitamin EClimacteric20091231031819415540
   PubMed Web of Science ®Google Scholar
• AndersenOEngebretsenTSolbergVMOrboAalpha-Methyldopa for climacteric hot flshes. A double-blind, randomized, cross-over studyActa Obstet Gynecol Scand1986654054093535358
   PubMed Web of Science ®Google Scholar
• NesheimBISaetreTReduction of menopausal hot flushes by methyldopa. A double blind crooser trialEur J Clin Pharmacol1981204134167026262
   PubMed Web of Science ®Google Scholar
• JacobsonJSTroxelABEvansJRandomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancerJ Clin Oncol2001192739274511352967
   PubMed Web of Science ®Google Scholar
• BorrelliFErnztEBlack cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacyPharmacol Res20085881418585461
   PubMed Web of Science ®Google Scholar
• LontosSJonesRMAngusPWGowPJAcute liver failure associated with the use of herbal preparations containing black cohoshMed J Aust200317939039114503910
   PubMed Web of Science ®Google Scholar
• MorganteGFarinaMCianciALa MarcaAPetragliaFde LeoVVeralipride administered with raloxifene decreases hot flushes and improve bone density in early postmenopausal womenGynecol Endocrinol20041819419815293890
   PubMed Web of Science ®Google Scholar
• CarrettiNFlorioPReisFMComaiSBertazzoAPetragliaFReduction of serum serotonin precursor after veralipride treatment for postmenopausal hot flushesClimacteric20101314114620082603
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Doc Ref. EMEA/299873/2007.
   Google Scholar
• World Health OrganizationMore risks tan benefits with veralipide; marketing authorization withdrawn for all medicinal products containing veralipride QSM/MC/IEA 11.6.2007723
   Google Scholar
• Norma Oficial Mexicana NOM-035-SSA2-2002, Prevención y control de enfermedades en la perimenopausia y postmenopausia de la mujer. Criterios para brindar la atención médica.
   Google Scholar
• DavidADonRTajchnerGWeissglasLVeralipride: alternative antidopaminergic treatment for menopausal symptomsAm J Obstet Gynecol1988158110711152967034
   PubMed Web of Science ®Google Scholar
• Diccionario de especialidades farmacéuticas56 edMéxico D.F.Thomson PLM S.A. de C.V.2010252253
   Google Scholar
• MelisGBGambaccianiMCagnacciAPaolettiAMMaisVFiorettiPEffects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal womenObstet Gynecol1988726886923140150
   PubMed Web of Science ®Google Scholar
• WeselSBourrguignonRPBosumaWBVeralipride versus conjugated oestrogens: a double-blind study in the management of menopausal hot flushesCurr Med Rev Opin19848696700
   PubMed Web of Science ®Google Scholar
• MelisGBGambaccianiMCagnacciAPaolettiAMMaisVFiorettiPEffects of dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal womenObstet Gynecol1988726886923140150
   PubMed Web of Science ®Google Scholar
• VercelliniPSacerdotePTrespidiLManfrediBPaneraiAECrosignaniPGVeralipride for hot flushes induced by a gonadotropin-releasing hormone agonist: a controlled studyFertil Steril1994629389427926138
   PubMed Web of Science ®Google Scholar
• BoukobzaGEfficacité et tolerance du veralipride dans le traitement des bouffes de chaleur de la menopause. Étude multicentriqueRev Fr Gynecol Obstet198684134173532280
   PubMedGoogle Scholar
• VercelliniPVendolaNColomboAPassadoreCTrespidiLCrosignianiPGVeralipride for hot flushes during gonadotropi-releasing hormone agonist treatmentGynecol Obstet Invest1992341021041398260
   PubMed Web of Science ®Google Scholar
• MaraisCPlace de l’Agreal dans le traitment de la menopauseRev Fr Gynecol Obstet1985801561623992113
   PubMedGoogle Scholar
• VerbekeKDhontMVandekerchhoveClinical and hormonal effects of long-term veralipride treatment on postmenopausal womenMaturitas1988102252303185294
   PubMed Web of Science ®Google Scholar
• MasmoudiKGras-ChampelVLemaire-HurtelASTroubles extrapyramidaux sous veralipride (Agreal), traitement symptomatique des bouffees de chaleur: a propos de 17 casRev Med Interne20052645345715936474
   PubMed Web of Science ®Google Scholar
• MontemurroDRossiGPVeralipride-induced acute coronary syndrome unmasking a non-secreting pheocromocytomaJ Endocrinol Invest20062965065216957415
   PubMed Web of Science ®Google Scholar
• Kunhardt-RaschJRodríguezCContreras-ChávezJRio de la Loza CavaFKarchmerSEficacia y seguridad del veralipride contra placebo en el tratamiento del síndrome climatéricoPerinatol Reprod Hum199152127
   Google Scholar
• RajaMAzzoniATardive dyskinesia after long-term veralipride treatmentJ Neuropsychiatry Clin Neurosci20051725225315939983
   PubMed Web of Science ®Google Scholar
• SinningOMMirandaMContrerasSATrastornos del movimiento inducidos por trazodona y veralipride: casos clínicosRev Chil Neuro-Psiquiat200543133136
   Google Scholar
• TeiveHAGSaDSWorsening of parkinsonism after the use of veralipride for treatment of menopause. Case reportArq Neuropsiquiatr20015912312411299446
   PubMed Web of Science ®Google Scholar
• Informe de farmacovigilancia, Laboratorios Carnot AF2009123
   Google Scholar
• RapkinAJVasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatmentAm J Obstet Gynecol20071969710617306645
   PubMed Web of Science ®Google Scholar